Taxanes Plus Trastuzumab Compared To Oral Vinorelbine Plus Trastuzumab in HER2-Overexpressing Metastatic Breast Cancer

BACKGROUND: This retrospective analysis was planned as a direct comparison of taxanes plus trastuzumab to the less toxic combination of oral vinorelbine (OV) plus trastuzumab as a first-line therapy for metastatic HER2-positive breast cancer. PATIENTS AND METHODS: Patients (n = 76) receiving either...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Breast Care (Basel)
Main Authors: Bergen, Elisabeth, Berghoff, Anna S., Rudas, Margaretha, Dubsky, Peter, De Vries, Catharina, Sattlberger, Claudia, Mader, Robert M., Zagouri, Flora, Sparber, Cornelia, Fitzal, Florian, Gnant, Michael, Rottenfusser, Andrea, Zielinski, Christoph C., Preusser, Matthias, Steger, Guenther G., Bartsch, Rupert
Formato: Artigo
Idioma:Inglês
Publicado: S. Karger GmbH 2014
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4322687/
https://ncbi.nlm.nih.gov/pubmed/25759615
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000368330
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares